samedan logo
 
 
spacer
home > ebr > winter 2008 > technological expression
PUBLICATIONS
European BioPharmaceutical Review

Technological Expression

Carola Schade at QIAGEN GmbH examines new methods of gene expression analysis for facilitating RNA purification in low-throughput laboratories

High-quality RNA is a major issue for researchers who analyse gene expression profiles. Due to increasing competition, they are seeking appropriate purification methods which are as efficient as possible. Automated solutions are therefore highly desirable. While automated platforms are already wellestablished in high-throughput laboratories, innovative technologies for low-throughput have only just been introduced.

The history of gene expression analysis began when laboratory methods were developed to examine the expression of individual genes. In the late 1970s, the ‘northern blot’ technique was the first method developed to detect gene expression. Since then, the rate at which new technologies are developed has been accelerating at an astounding pace and the range of starting materials being used in this type of experiment has broadened significantly. These novel technologies include quantitative real-time PCR and microarrays, which not only provide information on whether a gene is expressed at a given time or under specific conditions, but also allow the determination of quantitative levels of expression of target genes.

However, due to the high sensitivity of these methods, the accuracy of results is highly dependent on the quality of RNA samples, since any inconsistencies in sample preparation will be amplified in subsequent steps. Moreover, the purified RNA must also be free of contaminants such as chloroform and phenol, which may lead to inhibition of enzymes used in amplification and detection reactions.

SPIN COLUMN TECHNOLOGY

The introduction of silica membrane-based spin columns revolutionised the way RNA extraction is performed in life science research. The first spin column was developed for plasmid DNA purification in 1986. Since then, the technique has become the method used most often for DNA and RNA purification in laboratories worldwide. The principle behind this type of separation relies on nucleic acid molecules binding to a silica surface in the presence of specific salts and under certain pH conditions. Nucleic acids are adsorbed to silica surfaces in the presence of chaotropic salts, which remove water from hydrated molecules in solution. As polysaccharides and proteins are not adsorbed, they can easily be removed by various washing steps. After this procedure, the pure nucleic acids are eluted under low- or no-salt conditions, and ready for immediate use in demanding downstream applications, such as microarray analysis. To address the individual challenges of each starting material, numerous optimised kits have been developed.

AUTOMATED SOLUTIONS FOR IMPROVING STANDARDISATION AND LABOUR EFFICIENCIES

Due to the increasing amount of competition in the life science industry, researchers are looking for solutions that are as efficient as possible. Therefore, purification of nucleic acids has had to be taken to a higher, more time-saving and standardised level, and the development of a reliable, fully integrated and automated system was required. The development of automated medium- to high-throughput applications started over 15 years ago. In general, such applications are based on either 96-well formats or magnetic bead technologies. While automated systems are now wellestablished in high-throughput laboratories, the constantly increasing demand for automated solutions in low-throughput purification remained, and they have become available only recently. At first, the systems were based on magnetic bead technology. Currently, a small number of platforms based on this technology are available. The latest milestone has been achieved with the introduction of the first system capable of automating spin column technologies.


Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
5
     

There are no comments in regards to this article.

spacer
Dr Carola Schade joined QIAGEN GmbH, a leading supplier of sample and assay technologies, in 1999. Her current role involves the global product management of automated solutions. Carola studied at the Heinrich-Heine-University of Düsseldorf where she obtained her PhD in Biology at the Institute for Molecular Genetics.
spacer
Dr Carola Schade
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

4th Annual Patient Recruitment and Retention in Clinical Trials

13-15 October 2008, Amsterdam

Patient recruitment is now consuming thirty percent of clinical trial time - more time than any other clinical trial activity - and almost half of all trial delays result from patient recruitment problems. As the recruiting culture becomes more sophisticated and the forces affecting patient enrollment grow more numerous and complex, pharmaceutical companies are striving to discover new strategies to facilitate enrollment in clinical trials. With increasing industry pressure to develop, test and market greater numbers of new drugs faster, pharmaceutical companies need to perform clinical trials as quickly as possible. Inefficient patient recruitment processes is a formidable barrier to pharmaceutical companies' success in launching new products. Improving the patient recruitment process is imperative to avoid wasted investments and eliminate costly delays in bringing new drugs to market -- today and even more so in the not-so-distant future. Improved patient recruitment presents one of the largest opportunities for pharmaceutical companies to eliminate delays in clinical trials, thereby making it possible to reduce time to market.  With patent time limits and large overheads meaning that any delays in the development timeline can be disastrous, a good understanding of how to successfully recruit patients for trials is vital for any company looking to succeed.
More info >>

 
News and Press Releases

MipTec, October 14 – 16, 2008, Switzerland

MipTec about to take off by joining forces between Life Sciences Week, ALL-SystemsX.ch-Day, & Jobvector.com    
More info >>

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement